Member Info for mol42

perhaps because of what was noted Sep 2021 in this article and not fully explained in prior or subsequent RNS

https://www.cosmeticsdesign-europe.com/Article/2021/09/02/SkinBioTherapeutics-AxisBiotix-probiotic-powder-for-psoriasis-holds-wider-promise-says-CEO

mol

bit of recent exposure 01 Sep 2022 (albeit refers to a longer article back in May 2022 - which I don't think was referenced here but may be wrong )

https://www.naturalproductsinsider.com/digestive-health/beyond-gut-brain-axis

extract

Gut-skin axis

The phrase “healthier-looking skin starts from within” has never been truer. A more recent discovery than some of the other gut-organ relationships, the gut-skin axis links healthy skin to a balanced gut microbiome—the skin has its own microbiome, but it also appears to be influenced by the microbiome in the gut.

“There has been substantial research and data showing the direct relationship between the health of the gut and that of the skin,” reported Stuart Ashman, CEO of SkinBio Therapeutics. “Just think what happens when we eat foods that we’re allergic to and the resultant hives we see on the skin surface.”

According to Ashman, naturally reversing skin damage starts with healthy microbiota benefitted by select strains of “friendly bacteria” communicating through the gut-skin axis to reveal healthy skin.

“The health of the gut is more interactive with the rest of the body than just sending information back and forth,” he noted. “I’d say it was more like a conductor in an orchestra in directing the body’s health.”

mol

now into his 7th month of gardening leave

mol

of course it wasn't - lol - it never is once challenged

try and get my moniker right at least

that's mol - small m one l

mol

but it's perfectly ok to use same to give the distinct impression that sales were of that order - some were definitely lead up that path methinks - caveats and all

sometimes you just couldn't make it up - mind my lawnmower cuts through most of it - and is doing so again tonight

bw to everyone

mol

It was only 25 Aug belgrano you posted (extract)

Clearly with SBTX having sales over 50K a month, its 4 times what OPTI are achieving, in a very short time scale indeed.
Pure green eye confirmed. I'm not a OPTI holder anymore, but if I was I'd sell everything right now.
No comparison at all between the two.

seems like you were clearly wrong in your assertion re sales and unfortunately the comparison between the two regarding the recent released appalling sales figures by both is unfortunately very much comparable at present

That's not to say the figures won't diverge at some point in the future

I'm a direct holder in both albeit considerably more underwater in opti

bw all

mol

now registered

https://trademarks.ipo.gov.uk/ipo-tmcase/page/Results/1/UK00003792543

https://trademarks.ipo.gov.uk/ipo-tmcase/page/History/1/UK00003792543

mol

albeit we did have this from a couple of years ago

https://www.youtube.com/shorts/mrH-CLthq_0

with a different tag line - Gofigure with award -winning slimbiome

rather than how slimbiome works in Gofigure

that'll make all the difference -lol

mol

Looks like a new video

https://www.youtube.com/watch?v=Bg_EJ-PQTuI

from there to

https://gofigurediet.com/

and from there to

https://gofigurediet.com/shop-india/

https://gofigurediet.com/shop-saudi-arabia/

both of which feature slimbiome shots coming soon

https://gofigurediet.com/product/gofigure-supplement-powder-shot-with-slimbiome/

which don't appear on opti uk online store as far as i can see and also link on appears broken on undernoted

https://gofigurediet.com/about-us/

I got there via clicking India button top left

but to get shop saudi i had to go via site map

https://gofigurediet.com/sitemap/

website looks like WIP at moment

mol

published May 2022 and sponsored by sbtx

https://www.researchgate.net/publication/360565113_Multiple_Proteins_of_Lacticaseibacillus_rhamnosus_GG_Are_Involved_in_the_Protection_of_Keratinocytes_From_the_Toxic_Effects_of_Staphylococcus_aureus

mol

Looks the same to me from Mar 2022

and company subsequently used same in a tweet shortly thereafter - thx for recognition SA (not)

mol

6 months confirmed by the CEO designate

we wait and wait and wait......

Stephen no doubt is continuing to draw his salary, whilst looking to seek out further opportunities (his expertise in his words) for Opti, and congratulating himself but ignoring the fact that this is now a listed plc but according to admission document

an agreement between Stephen O’Hara and ProBiotix dated 31 March 2022, pursuant to which Mr O’Hara agreed to act as Chief Executive Officer of ProBiotix on a part time basis committing a minimum of 18½ hours per week. In the absence of breach, the appointment is terminable on six months’ notice on either side. The salary payable to Mr O’Hara is £106,000 per annum. Mr O’Hara has agreed to post termination restrictions on competing activity, which commence on termination of the appointment (such that no period of gardening leave shall be counted as part of the restricted period). Mr O’Hara
previously carried out duties for ProBiotix as part of shared services with OptiBiotix

said document as we know not within our purview prior to release

mind we should be used to used to obfuscation in all things Opti and especially with our part time CEO and of course with six months notice and gardening leave restrictions not applying to him

mol

now on Knowde

https://www.knowde.com/stores/sacco-system/

we know lpldl listed as well under optibiotix

https://www.knowde.com/stores/optibiotix-health-plc/

mol

Seed DS-01 mentioned twice

https://www.innerbody.com/best-probiotic-for-men

Best for cardiovascular health and low-FODMAP dieters

Pros
Free from most allergens
Designated glyphosate-free
Great choice for low FODMAP diets
Comes with a convenient travel vial
Free shipping in the US
Powdered option for kids and teens
Great return policy
Strains validated by whole-genome sequencing

Cons
Can only be purchased as a subscription
A tad on the pricey side

Seed offers one of the most scientifically rigorous approaches to the development of a probiotic, and they pour that research and attention into a single product for adults and a single product for children and teens. They mind every important detail to ensure you get a product that doesn’t sacrifice convenience for efficacy or sustainability for quality.

For example, Seed uses probiotic strains that other companies avoid because they require special capsule coatings and, occasionally, refrigeration. But Seed developed an encapsulation system that protects these strains from stomach acid while preserving them at room temperature. They also provide you with a reusable jar in your first shipment and send all subsequent shipments in recyclable bags to cut down on waste.

The Seed website also offers plenty of useful information for anyone curious about their manufacturing processes or the microbiome in general. And if you’re unsatisfied with their product, you can get a full refund on your first shipment without even sending anything back to the company.

Noteworthy strains for men’s health found in Seed DS-01 include L. plantarum SD-LPLDL-UK and B. lactis SD-MB2409-IT.

mol

thx for your previous comment btw (I did vote up)

nevermind your gut nor mine, which is proving difficult to shift whether post holiday or not lol,

a substantial shift in SP would allow me to go on a few more holidays!

holding more than our CEO of Optibiotix Ltd, and now a main board member of plc of course, and S Hammond

mol

myprotein have introduced a sample at £2.49

https://www.myprotein.com/elysium.search?search=leanbiome

https://www.myprotein.com/sports-nutrition/impact-diet-lean-sample/13174407.html

and is ranked as one of the most popular on uk site at present

hopefully will lead to increased purchase of main product in due course

at least they are trying to be inventive in these difficult economic times

albeit still not on US/Canada websites

mol

I'm not on twitter but keep an eye on our tweets (can get the latest 2-3 as no doubt any of you not on twitter can ) and also don't pay much attention to these reports - an example noted in company tweet

mind retrieved the undernoted - 12th August 2022 tweet

https://twitter.com/OptiBiotix/status/1558045708476899328

According to @expertmresearch
, the weight management market is projected to reach $602.5 billion in 2027.

OptiBiotix is well-positioned to take advantage of this with its award-winning ingredient SlimBiome®.

Discover SlimBiome®’s potential here: https://optibiotix.com/products/

£120,000 6 mths to 30 June 2022

haven't bothered to work out that % of same market but presumably we're also paying someone to post this stuff which is of course not doing anything for our turnover but more importantly possibly damaging our reputation

sometimes it is better to work quietly behind the scenes and then hopefully let the figures speak for themselves - eventually of course in our case as rns today has amply demonstrated

think that's me finished on this topic

but you never know....................

mol

12/08/22 | 09:23 GB00BLNBFR86 50000 21.5
08/08/22 | 12:21 GB00BLNBFR86 100000 21.5
08/08/22 | 12:21 GB00BLNBFR86 100000 21.45
18/07/22 | 13:50 GB00BLNBFR86 7000 21
18/07/22 | 13:49 GB00BLNBFR86 5000 21
01/07/22 | 12:54 GB00BLNBFR86 11000 21.1001
29/06/22 | 14:35 GB00BLNBFR86 7500 21.869
28/06/22 | 09:41 GB00BLNBFR86 3500 21.9
21/06/22 | 16:19 GB00BLNBFR86 1664 21.97
08/06/22 | 12:22 GB00BLNBFR86 1664 21
25/05/22 | 08:01 GB00BLNBFR86 1008 21.97
16/05/22 | 10:50 GB00BLNBFR86 1046 21.97
13/05/22 | 12:07 GB00BLNBFR86 1325 21.97
05/05/22 | 14:39 GB00BLNBFR86 3596 21.97
26/04/22 | 13:24 GB00BLNBFR86 7563 21.97
06/04/22 | 14:42 GB00BLNBFR86 100 21.45
04/04/22 | 14:13 GB00BLNBFR86 9100 21.8
01/04/22 | 15:54 GB00BLNBFR86 2309 21.3
01/04/22 | 11:59 GB00BLNBFR86 2075 21.2
01/04/22 | 09:15 GB00BLNBFR86 28 21.2

just for interest

mol

https://www.thebusinessdesk.com/yorkshire/news/2098455-tough-trading-environment-hits-h1-sales-at-life-sciences-company

The York-headquartered firm’s update states: “We believe the difference in sales is partly a timing issue with a couple of larger partners delaying restocking due to uncertainty in the economic environment, and Apollo Hospitals and Nahdi Medical postponing launches until H2 as a result of regulatory approvals taking longer than expected.”

Considering Apollo and Nahdi were never in sales previously a bit disingenuous to consider they had any impact on comparing this H1 with previous H1 though perhaps they meant this H1 sales lower than they expected (ie company) rather than comparing with H1 2021 but the comment in the RNS was preceded with

The listing of PBX on AQSE means that it is now considered an associate for accounting purposes with its revenues and costs removed and only OptiBiotix’s (44%) proportion of its profit and loss included in the Company’s accounts.

This makes year on year comparisons challenging.

Based on initial figures, we expect current sales in the Group’s new structure to be materially lower than expected, at around £120K, with sales normalising in H2 but insufficient to make up the H1 deficit and returning to healthy growth in 2023.

in any event an appalling first six months

mol

Aquae got there before me re comparatives - the turnover figure is certainly below what I was expecting - and definitely a huge disappointment. Presumably we won't see a reduction in Directors' salaries though hardly an endorsement of our CEO's first 17 mths in charge and whilst not the easiest economic climate in recent months it was only 1 March when he commented (one third into period under consideration released today)

René Kamminga, CEO of OptiBiotix Ltd, commented: "In the past 12 months we have established the credibility and brand awareness of our science-based ingredients SlimBiome®, OptiBiome, LeanBiome and LPLDL® ingredients, significantly growing sales to a wider number of reputable global brands in multiple markets. These appointments are a further investment to accelerate the growth of the Company and to broaden and deepen our income streams with a particular focus on North America and E-Commerce."

RNS at least explains why nothing could be found on Apollo Hospitals and Nahdi Medical sites or the regulatory site - albeit this again is very disappointing.

Mind we should expect delays, low income generating contracts, cancelled contracts etc in all things Opti

I think i read somewhere that Stephen was quoted as saying he was building a business not a share price - doesn't seem to be succeeding at either at the moment.

Anyway still here, though at a considerable loss, and will continue to hold at present in the hope that sweetbiotix will be the saving grace (though i don't expect that will turn us into Stephen's £600m company comment any time soon - if ever)

just a few initial comments

mol